Puma Biotechnology PBYI
NASDAQ PBYI
$9.55 +0.14 (+1.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Puma Biotechnology (PBYI) Receivables - Other (2012 - 2019)

Puma Biotechnology's (PBYI) quarterly Receivables - Other came in at $9.9 million in Q1 2019, up 743.57% on a QoQ basis from $1.2 million in Q4 2018.

Analysis

Puma Biotechnology (PBYI) Receivables - Other (2012 - 2019) Analysis & Trends

Puma Biotechnology (PBYI) has 5 years of Receivables - Other data on file, last reported at $9.9 million in Q1 2019.

  • Quarterly Receivables - Other changed N/A year-over-year to $9.9 million in Q1 2019, while the trailing twelve-month figure through Mar 2019 was $9.9 million (changed N/A YoY) and the FY2018 annual result came in at $1.2 million, changed N/A from the prior year.
  • Receivables - Other rose to $9.9 million in Q1 2019, from $1.2 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $11.2 million in Q3 2018 to a low of $1.2 million in Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Puma Biotechnology 486.99 Mn 393.08 Mn 44.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 9.91 Mn
Dec 31, 2018 1.18 Mn
Sep 30, 2018 11.23 Mn
Sep 30, 2014 1.76 Mn
Jun 30, 2014 1.76 Mn
Mar 31, 2014 13.30 Mn
Dec 31, 2013 -1.48 Mn
Sep 30, 2013 11.29 Mn
Jun 30, 2013 14.77 Mn
Mar 31, 2013 17.34 Mn
Dec 31, 2012 10.61 Mn